Confirming identity: what mass spectrometry adds that HPLC cannot
How electrospray ionisation, charge-state deconvolution and peptide mapping establish which compound is in a vial — and why a matching molecular weight is necessary but not sufficient.
Purity and identity are different questions, and only one of them is routinely answered. Purity asks how much of a sample is a single compound. Identity asks which compound that is. A supplier running purity alone can report a high figure with complete accuracy and still have shipped the wrong molecule.
Why retention time is not identification
It is tempting to treat a chromatographic peak in the expected place as confirmation. Retention time is reproducible under a fixed method, and a peak appearing where the reference material appears is genuine evidence. It is just weak evidence, for a structural reason: retention in reversed-phase chromatography is governed by overall hydrophobicity, and hydrophobicity is not unique to a sequence.
Species that can share a retention window include truncated sequences missing a residue that contributed little to hydrophobicity, deletion sequences, diastereomers arising from racemisation during synthesis, and unrelated compounds that simply partition similarly. Retention time narrows the field. It does not close it.
What mass spectrometry measures
A mass spectrometer does not weigh molecules directly. It measures the mass-to-charge ratio of ions, which means the sample must first be ionised and carried into the gas phase without being destroyed. For peptides, electrospray ionisation is the standard method.
In electrospray, the sample in solution is pushed through a fine capillary held at high voltage. The emerging liquid forms a charged aerosol; as solvent evaporates the droplets shrink until charge density forces ions into the gas phase. It is gentle enough to leave the peptide backbone intact, which is what makes it suitable for intact-mass work.
Charge states and deconvolution
Electrospray of a peptide does not produce one signal. Basic sites across the molecule pick up protons independently, so the same compound appears as a series of peaks at different charge states — singly, doubly, triply protonated and so on — each at a different mass-to-charge ratio.
This looks like a complication and is in fact a benefit. The charge-state envelope is internally consistent: every peak in it must resolve to the same neutral mass. Deconvolution software collapses the series into a single molecular weight, and the agreement between charge states is itself a check that the peaks belong to one species rather than several.
The deconvoluted mass is compared against the theoretical mass calculated from the sequence on the label. Agreement within the instrument tolerance is the identity result. A discrepancy is diagnostic: a shortfall matching a residue mass points to a deletion sequence, and a defined excess often points to oxidation or an incomplete deprotection.
Where intact mass runs out
A matching molecular weight is necessary but not sufficient, because mass is a sum and sums do not preserve order. Two peptides containing exactly the same residues in a different sequence have identical molecular formulae and identical masses. Leucine and isoleucine are structural isomers and cannot be told apart by mass at all. Some small peptides yield limited fragment information even under conditions designed to produce it, and require dedicated approaches to elucidate structure [2].
Where sequence itself has to be confirmed, the method is tandem mass spectrometry. Selected ions are isolated and fragmented, characteristically along the backbone, and the resulting fragment masses are read as a ladder from which the sequence can be reconstructed. Applied systematically after enzymatic digestion, this is peptide mapping — the established approach for sequence confirmation in therapeutic protein characterisation [1].
Why the methods are run together
Chromatography and mass spectrometry answer different questions and have complementary blind spots, which is precisely why they are coupled. Directly hyphenating the two lets the mass detector report what is present at each point across a chromatographic peak, so a co-eluting impurity that is invisible to ultraviolet area normalisation becomes visible as a second mass under the same peak [3].
| Method | Answers | Blind to |
|---|---|---|
| RP-HPLC, UV detection | What proportion of the sample is one species | Which species it is; co-eluting impurities |
| Intact mass by ESI-MS | Whether the molecular weight matches the sequence | Sequence order; isomers of equal mass |
| Tandem MS / peptide mapping | The sequence itself | Quantity; non-peptide contamination |
What to look for on a certificate
- 01An identity row that is distinct from the purity row, not a restatement of it.
- 02The method named — MS, LC-MS or MS/MS — rather than an unattributed pass.
- 03Theoretical and observed mass, so the comparison can be checked rather than trusted.
- 04For blends, a result per constituent, since a single mass cannot characterise a mixture.
Identity on our release specification is confirmed by HPLC and MS together rather than inferred from retention time, and it is reported as its own line on every product page.
This article describes analytical methodology. It does not describe the use, effect or application of any compound. All products are supplied for laboratory and research purposes only.
Primary sources for the analytical claims above, linked so you can read them directly rather than take our word for it.
- [1]Peptide Mapping for Sequence Confirmation of Therapeutic Proteins and Recombinant Vaccine Antigens by High-Resolution Mass Spectrometry: Software Limitations, Pitfalls, and Lessons LearnedDobrowolski M, Urbaniak M, Pietrucha T · Int J Mol Sci · 2025 · PMID 41155256
- [2]Structural elucidation of dipeptides displaying limited mass spectral information by liquid chromatography-electrospray ionization-tandem mass spectrometryMadmon M, Weissberg A · J Mass Spectrom · 2021 · PMID 34333821
- [3]Analysis of short-chain bioactive peptides by unified chromatography-electrospray ionization mass spectrometry. Part II. Comparison to reversed-phase ultra-high performance liquid chromatographyMolineau J, Hideux M, Hennig P et al. · J Chromatogr A · 2022 · PMID 34973481
